COGENT (COlorectal cancer GENeTics) revisitedHOULSTON, Richard S.Mutagenesis. 2012, Vol 27, Num 2, pp 143-151, issn 0267-8357, 9 p.Article

Ancestral susceptibility to colorectal cancerHUHN, Stefanie; PARDINI, Barbara; NACCARATI, Alessio et al.Mutagenesis. 2012, Vol 27, Num 2, pp 197-204, issn 0267-8357, 8 p.Article

The role of ABC transporters in progression and clinical outcome of colorectal cancerHLAVATA, I; MOHEINIKOVA-DUCHONOVA, B; VODICKA, P et al.Mutagenesis. 2012, Vol 27, Num 2, pp 187-196, issn 0267-8357, 10 p.Article

Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresisMUTO, Taika; TANIGUCHI, Hirokazu; NAKAMURA, Yukiko et al.Journal of proteomics (Print). 2011, Vol 74, Num 6, pp 858-873, issn 1874-3919, 16 p.Article

What can we do about low colorectal cancer screening rates?RABENECK, Linda.The American journal of gastroenterology. 2007, Vol 102, Num 8, pp 1736-1738, issn 0002-9270, 3 p.Article

Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancersDE MIRANDA, Noel F. C. C; HES, Frederik J; WEZEL, Tom Van et al.Mutagenesis. 2012, Vol 27, Num 2, pp 247-253, issn 0267-8357, 7 p.Article

Preparation and Characterizations of Polyclonal Antibodies Against STAR Protein QKI7bQIUYAN LIU; YU LUO; XIAOTONG LI et al.Applied biochemistry and biotechnology. 2013, Vol 169, Num 8, pp 2273-2280, issn 0273-2289, 8 p.Article

Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experienceCASTELLVI-BEL, Sergi; RUIZ-PONTE, Clara; LLOR, Xavier et al.Mutagenesis. 2012, Vol 27, Num 2, pp 153-159, issn 0267-8357, 7 p.Article

Colorectal cancers under 45 years of ageZORLUOGLU, Abdullah; YILMAZLAR, Tuncay; OZGUC, Halil et al.Hepato-gastroenterology. 2004, Vol 51, Num 55, pp 118-120, issn 0172-6390, 3 p.Article

Is there a link between work-related stress and colorectal cancer?SPIGELMAN, Allan D; DWYER, Peter.Medical journal of Australia. 2004, Vol 180, Num 7, pp 339-340, issn 0025-729X, 2 p.Article

The influence of selenium and selenoprotein gene variants on colorectal cancer riskMEPLAN, Catherine; HESKETH, John.Mutagenesis. 2012, Vol 27, Num 2, pp 177-186, issn 0267-8357, 10 p.Article

Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancerTOMLINSON, Ian P. M; HOULSTON, Richard S; MONTGOMERY, Grant W et al.Mutagenesis. 2012, Vol 27, Num 2, pp 219-223, issn 0267-8357, 5 p.Article

Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progressionPLASCHKE, Jens; KRÜGER, Stefan; JESKE, Birgit et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 864-870, issn 0008-5472, 7 p.Article

Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controlsSLYSKOVA, Jana; NACCARATI, Alessio; PARDINI, Barbara et al.Mutagenesis. 2012, Vol 27, Num 2, pp 225-232, issn 0267-8357, 8 p.Article

Survivin and molecular pathogenesis of colorectal cancerKIM, Paul J; PLESCIA, Janet; CLEVERS, Hans et al.Lancet (British edition). 2003, Vol 362, Num 9379, pp 205-209, issn 0140-6736, 5 p.Article

Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer riskPARDINI, Barbara; NACCARATI, Alessio; VODICKA, Pavel et al.Mutagenesis. 2012, Vol 27, Num 2, pp 161-167, issn 0267-8357, 7 p.Article

Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerDE GRAMONT, Aimery; BUYSE, Marc; CAROLA, Elisabeth et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3224-3229, issn 0732-183X, 6 p.Article

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer : Results from intergroup N9741DY, Grace K; KROOK, James E; POCKAJ, Barbara A et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3469-3474, issn 0732-183X, 6 p.Article

Statins and the risk of colorectal cancer : A meta-analysis of 18 studies involving more than 1.5 million patientsBONOVAS, Stefanos; FILIOUSSI, Kalitsa; FLORDELLIS, Christodoulos S et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3462-3468, issn 0732-183X, 7 p.Article

Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancerALBRETHSEN, Jakob; BØGEBO, Rikke; MØLLER, Christian H et al.Proteomics. Clinical applications (Print). 2012, Vol 6, Num 3-4, pp 182-189, issn 1862-8346, 8 p.Article

Mutations and polymorphisms in TP53 gene—an overview on the role in colorectal cancerNACCARATI, A; POLAKOVA, V; PARDINI, B et al.Mutagenesis. 2012, Vol 27, Num 2, pp 211-218, issn 0267-8357, 8 p.Article

Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomesKIM, Hye-Jung; KANG, Un-Beom; LEE, Hanna et al.Journal of proteomics (Print). 2012, Vol 75, Num 10, pp 2983-2997, issn 1874-3919, 15 p.Conference Paper

Induction of cell growth arrest by atmospheric non-thermal plasma in colorectal cancer cellsKIM, Chul-Ho; JAE HOON BAHN; LEE, Seong-Ho et al.Journal of biotechnology. 2010, Vol 150, Num 4, pp 530-538, issn 0168-1656, 9 p.Article

Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancerENGWEGEN, Judith Y. M. N; ALBERTS, Marieke; SCHELLENS, Jan H. M et al.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 6, pp 936-945, issn 1862-8346, 10 p.Article

The subserosal elastic lamina: An anatomic landmark for stratifying pT3 colorectal cancerSHINTO, Eiji; UENO, Hideki; HASHIGUCHI, Yojiro et al.Diseases of the colon & rectum. 2004, Vol 47, Num 4, pp 467-473, issn 0012-3706, 7 p.Article